BioSpace News Archive

Business

Rubius Therapeutics to Acquire Manufacturing Facility in Smithfield, Rhode Island to Produce Red Cell Therapeutics

Rubius Therapeutics, Inc. (Nasdaq: RUBY), today announced that it has signed a purchase and sale agreement for the acquisition of a 135,000-square foot manufacturing facility located in Smithfield, Rhode Island.

July 25, 2018
·
4 min read
Policy

Baxter Announces Health Canada Approval of Spectrum IQ Infusion System

Designed with Exclusive New Features for Bi-Directional Electronic Medical Records Integration Including Auto-Programming and Auto-Documentation

July 25, 2018
·
4 min read
Business

Evidence-Based Behavioral and Cognitive Science Now Applied to Cardiac Condition Management to Increase Patient Activation

American Heart Association’s Center for Health Technology and Innovation Collaborates with GoMo Health for the Prevention and Treatment of Cardiac Conditions and Associated Comorbidities

July 25, 2018
·
3 min read
Business

New Directions Behavioral Health moves to Sprint campus in Overland Park

New Directions Behavioral Health announced plans to move its headquarters from Kansas City, Missouri to the Sprint campus in Overland Park, Kansas. The company recently finalized terms of the new lease, which will begin in April 2019.

July 25, 2018
·
2 min read
Drug Development

Glenmark Pharmaceuticals Announces Encouraging Phase 1 Results Supporting Biosimilarity Criteria for GBR 310 Compared to the Reference Product Omalizumab

Glenmark is seeking use of GBR 310 for the same indications as the reference biologic for the treatment of allergic asthma and chronic idiopathic urticaria (CIU)

July 25, 2018
·
4 min read
Business

Evolent Health to Participate in Upcoming Investor Conference

Evolent Health, Inc. announced that Chief Executive Officer & Co-Founder Frank Williams and Chief Financial Officer Nicky McGrane will participate in an upcoming investor conference.

July 25, 2018
·
1 min read
BioMidwest

AAIC® 2018 Features First Clinical Trial to Show Intensive Blood Pressure Treatment Reduces New Cases of Mild Cognitive Impairment and Dementia (Combined Endpoint)

CONFERENCE ALSO RELEASES FIRST-EVER DEMENTIA DATA IN LGB SENIORS, AND WOMEN’S DEMENTIA RISK RELATED TO REPRODUCTIVE HISTORY

July 25, 2018
·
13 min read
Pharm Country

New PBM Model Places Patients First, Delivers Effective Coordination Of Care

President Trump Wants to Reduce Patient Out-of-Pocket Costs. BeneCard PBF’s Expert Clinical Care Coordination Improves Patient Safety and Reduces Costs by Combatting Inappropriate Prescribing.

July 25, 2018
·
2 min read
Pharm Country

Siemens Healthineers Transforms Care Delivery with Innovative New Tests for Diagnosing Heart Attacks Faster

The Siemens Healthineers High-Sensitivity Troponin I assays can detect lower levels of troponin compared to conventional assays.

July 25, 2018
·
3 min read
Drug Development

Eisai And Biogen Present Detailed Results From Phase II Clinical Study Of Elenbecestat In MCI And Mild To Moderate Alzheimer’s Disease At Alzheimer’s Association International Conference (AAIC) 2018

Eisai Co., Ltd. and Biogen Inc. announced detailed results from a Phase II clinical study (Study 202) of the investigational oral BACE (beta amyloid cleaving enzyme) inhibitor elenbecestat (development code: E2609) at the Alzheimer’s Association International Conference (AAIC) 2018

July 25, 2018
·
12 min read